Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer
- 23 July 2015
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 367 (2), 138-146
- https://doi.org/10.1016/j.canlet.2015.07.015
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Lung Cancer in ChinaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Non‐coding RNAs in cancer initiation and progression and as novel biomarkersMolecular Oncology, 2011
- The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug TargetsPharmaceutical Research, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerProceedings of the National Academy of Sciences of the United States of America, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008